Multidisciplinary Treatment of Advanced Soft Tissue Sarcomas

Multidisciplinary Treatment of Advanced Soft Tissue Sarcomas

Episodes

Specialty:

All

Year:

All

EP. 1: Incidence and Subtypes of Advanced Soft Tissue Sarcoma

October 21st 2015

EP. 2: Accurately Diagnosing Soft Tissue Sarcoma

October 21st 2015

EP. 3: Multidisciplinary Assessment of Soft Tissue Sarcomas

October 21st 2015

EP. 4: Implementation of Multidisciplinary Sarcoma Care

October 21st 2015

EP. 5: Key Members of the Multidisciplinary Team

October 21st 2015

EP. 6: Integrating Community Oncologists Into the Multidisciplinary Team

October 21st 2015

EP. 7: Importance of Surgery and Radiation in Advanced STS

October 21st 2015

EP. 8: Chemotherapy Regimens for Advanced Soft Tissue Sarcoma

October 21st 2015

EP. 9: Chemotherapy Toxicity Considerations in Soft Tissue Sarcoma

October 21st 2015

EP. 10: Subtyping in Soft Tissue Sarcoma: The PALLETTE Study

October 21st 2015

EP. 11: Use of Trabectedin in Soft Tissue Sarcoma

October 21st 2015

EP. 12: Patient Selection in Soft Tissue Sarcoma

October 21st 2015

EP. 13: Early Data With Olaratumab in Soft Tissue Sarcoma

October 21st 2015

EP. 14: Phase III Data on Eribulin in Advanced STS

October 21st 2015

EP. 15: Future Directions in Soft Tissue Sarcoma

October 21st 2015

Trending on OncLive

FDA Approves Rusfertide for Polycythemia Vera

DESTINY-Breast05 Safety Analysis Clarifies ILD and Radiation Risks With T-DXd in HER2+ Breast Cancer

FDA Approves Daraxonrasib for Metastatic Pancreatic Ductal Adenocarcinoma

DAWN-303 Trial Set to Advance INCB161734 in First-Line KRAS G12D–Mutated Metastatic Pancreatic Cancer

First-Line Ivonescimab Plus Chemotherapy Meets OS End Point in Advanced Biliary Tract Cancer